Healthcare

Acknowledged for our partnership style, we bring our investment expertise, sector insight and relationships to build lasting value within healthcare businesses throughout Europe, Asia and the Americas.

Since April 2001, 3i has invested €1.8bn in 37 healthcare companies internationally.

We invest in three core sub-sectors:

• Pharmaceuticals and biotechnology: Within this wide-ranging sector, we see opportunities in these key areas: Specialty Pharma, Generics / OTC, Drug Delivery and Animal Health.
• Healthcare Services: This is the largest and most rapidly evolving sub-sector within the global healthcare industry and includes activities such as elderly and specialty care for people in their own homes, in hospitals and in community facilities, as well as operational services such as outsourced clinical and support services and B2B contract services.
• Medical devices and technology: This sub-sector deals with a range of devices, medical equipment, consumables, diagnostics and healthcare IT which provide the means to identify the nature of health conditions and to allow intervention with methods that increase life span and/or improve the quality of care and quality of life.

Across the world, the upward trend in healthcare spending is relentless, driven by powerful and enduring factors: aging populations in Europe and the Americas, rising affluence in Asia, and a widespread mindset that expects every new treatment to be instantly available.

These fundamental drivers of growth make Healthcare a resilient and compelling sector for investors, especially at times of global uncertainty. Therefore, products and services which help drive down healthcare costs while improving the quality of service are of particular interest.

At 3i, our team of Healthcare professionals has an on-the-ground presence in three continents and a valuable network of experts including clinicians, policy-makers and key people at the corporate healthcare providers. By taking a global view of trends and migrating innovation to where it is needed, we are playing a strong part in building efficient international healthcare businesses.